At the 2023 World Congress on Gastrointestinal Cancers, Akihito Kawazoe, MD, shared results from the phase 3 LEAP-017 trial, evaluating lenvatinib plus pembrolizumab among previously treated patients with metastatic colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Akihito Kawazoe, MD, shared results from the phase 3 LEAP-017 trial, evaluating lenvatinib plus pembrolizumab among previously treated patients with metastatic colorectal cancer.
At the 2023 World Congress on...